These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Rationally designed AAV2 and AAVrh8R capsids provide improved transduction in the retina and brain. Sullivan JA; Stanek LM; Lukason MJ; Bu J; Osmond SR; Barry EA; O'Riordan CR; Shihabuddin LS; Cheng SH; Scaria A Gene Ther; 2018 Jun; 25(3):205-219. PubMed ID: 29785047 [TBL] [Abstract][Full Text] [Related]
25. The role of the adeno-associated virus capsid in gene transfer. Van Vliet KM; Blouin V; Brument N; Agbandje-McKenna M; Snyder RO Methods Mol Biol; 2008; 437():51-91. PubMed ID: 18369962 [TBL] [Abstract][Full Text] [Related]
26. Bat adeno-associated viruses as gene therapy vectors with the potential to evade human neutralizing antibodies. Li Y; Li J; Liu Y; Shi Z; Liu H; Wei Y; Yang L Gene Ther; 2019 Jun; 26(6):264-276. PubMed ID: 31110296 [TBL] [Abstract][Full Text] [Related]
27. Engineered AAV vector minimizes in vivo targeting of transduced hepatocytes by capsid-specific CD8+ T cells. Martino AT; Basner-Tschakarjan E; Markusic DM; Finn JD; Hinderer C; Zhou S; Ostrov DA; Srivastava A; Ertl HC; Terhorst C; High KA; Mingozzi F; Herzog RW Blood; 2013 Mar; 121(12):2224-33. PubMed ID: 23325831 [TBL] [Abstract][Full Text] [Related]
28. Pre-existing immunity to adeno-associated virus (AAV)2 limits transgene expression following intracerebral AAV2-based gene delivery in a 6-hydroxydopamine model of Parkinson's disease. Janelidze S; Nordström U; Kügler S; Brundin P J Gene Med; 2014; 16(9-10):300-8. PubMed ID: 25303717 [TBL] [Abstract][Full Text] [Related]
29. Adeno-associated virus (AAV) serotypes 2, 4 and 5 display similar transduction profiles and penetrate solid tumor tissue in models of human glioma. Thorsen F; Afione S; Huszthy PC; Tysnes BB; Svendsen A; Bjerkvig R; Kotin RM; Lønning PE; Hoover F J Gene Med; 2006 Sep; 8(9):1131-40. PubMed ID: 16810631 [TBL] [Abstract][Full Text] [Related]
30. Ocular Inflammatory Response to Intravitreal Injection of Adeno-Associated Virus Vector: Relative Contribution of Genome and Capsid. Timmers AM; Newmark JA; Turunen HT; Farivar T; Liu J; Song C; Ye GJ; Pennock S; Gaskin C; Knop DR; Shearman MS Hum Gene Ther; 2020 Jan; 31(1-2):80-89. PubMed ID: 31544533 [TBL] [Abstract][Full Text] [Related]
31. A novel adeno-associated virus capsid with enhanced neurotropism corrects a lysosomal transmembrane enzyme deficiency. Tordo J; O'Leary C; Antunes ASLM; Palomar N; Aldrin-Kirk P; Basche M; Bennett A; D'Souza Z; Gleitz H; Godwin A; Holley RJ; Parker H; Liao AY; Rouse P; Youshani AS; Dridi L; Martins C; Levade T; Stacey KB; Davis DM; Dyer A; Clément N; Björklund T; Ali RR; Agbandje-McKenna M; Rahim AA; Pshezhetsky A; Waddington SN; Linden RM; Bigger BW; Henckaerts E Brain; 2018 Jul; 141(7):2014-2031. PubMed ID: 29788236 [TBL] [Abstract][Full Text] [Related]
32. Transduction of the central nervous system after intracerebroventricular injection of adeno-associated viral vectors in neonatal and juvenile mice. Gholizadeh S; Tharmalingam S; Macaldaz ME; Hampson DR Hum Gene Ther Methods; 2013 Aug; 24(4):205-13. PubMed ID: 23808551 [TBL] [Abstract][Full Text] [Related]
33. Mutants at the 2-Fold Interface of Adeno-associated Virus Type 2 (AAV2) Structural Proteins Suggest a Role in Viral Transcription for AAV Capsids. Aydemir F; Salganik M; Resztak J; Singh J; Bennett A; Agbandje-McKenna M; Muzyczka N J Virol; 2016 Aug; 90(16):7196-7204. PubMed ID: 27252527 [TBL] [Abstract][Full Text] [Related]
34. Transduction of rat pancreatic islets with pseudotyped adeno-associated virus vectors. Craig AT; Gavrilova O; Dwyer NK; Jou W; Pack S; Liu E; Pechhold K; Schmidt M; McAlister VJ; Chiorini JA; Blanchette-Mackie EJ; Harlan DM; Owens RA Virol J; 2009 May; 6():61. PubMed ID: 19450275 [TBL] [Abstract][Full Text] [Related]
35. Rational downstream development for adeno-associated virus full/empty capsid separation - A streamlined methodology based on high-throughput screening and mechanistic modeling. Keller WR; Picciano A; Wilson K; Xu J; Khasa H; Wendeler M J Chromatogr A; 2024 Feb; 1716():464632. PubMed ID: 38219623 [TBL] [Abstract][Full Text] [Related]
36. Intraocular route of AAV2 vector administration defines humoral immune response and therapeutic potential. Li Q; Miller R; Han PY; Pang J; Dinculescu A; Chiodo V; Hauswirth WW Mol Vis; 2008 Sep; 14():1760-9. PubMed ID: 18836574 [TBL] [Abstract][Full Text] [Related]
37. Cross-presentation of adeno-associated virus serotype 2 capsids activates cytotoxic T cells but does not render hepatocytes effective cytolytic targets. Wang L; Figueredo J; Calcedo R; Lin J; Wilson JM Hum Gene Ther; 2007 Mar; 18(3):185-94. PubMed ID: 17324107 [TBL] [Abstract][Full Text] [Related]
38. Antibody neutralization poses a barrier to intravitreal adeno-associated viral vector gene delivery to non-human primates. Kotterman MA; Yin L; Strazzeri JM; Flannery JG; Merigan WH; Schaffer DV Gene Ther; 2015 Feb; 22(2):116-26. PubMed ID: 25503696 [TBL] [Abstract][Full Text] [Related]
39. Impact of Heparan Sulfate Binding on Transduction of Retina by Recombinant Adeno-Associated Virus Vectors. Boye SL; Bennett A; Scalabrino ML; McCullough KT; Van Vliet K; Choudhury S; Ruan Q; Peterson J; Agbandje-McKenna M; Boye SE J Virol; 2016 Apr; 90(8):4215-4231. PubMed ID: 26865709 [TBL] [Abstract][Full Text] [Related]
40. Analytical characterization of full, intermediate, and empty AAV capsids. McColl-Carboni A; Dollive S; Laughlin S; Lushi R; MacArthur M; Zhou S; Gagnon J; Smith CA; Burnham B; Horton R; Lata D; Uga B; Natu K; Michel E; Slater C; DaSilva E; Bruccoleri R; Kelly T; McGivney JB Gene Ther; 2024 May; 31(5-6):285-294. PubMed ID: 38374348 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]